Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123574553 | 12357455 | 3 | F | 20160503 | 20160927 | 20160511 | 20160929 | PER | US-CELGENEUS-USA-2016051576 | CELGENE | 69.45 | YR | M | Y | 0.00000 | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123574553 | 12357455 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | UNKNOWN | 20785 | 50 | MG | CAPSULES | BID | |||||
| 123574553 | 12357455 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 50 MILLIGRAM | U | UNKNOWN | 20785 | 50 | MG | CAPSULES | BID | ||||
| 123574553 | 12357455 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 50-150 MG | U | UNKNOWN | 20785 | CAPSULES | |||||||
| 123574553 | 12357455 | 4 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | UNKNOWN | 20785 | 50 | MG | CAPSULES | BID | |||||
| 123574553 | 12357455 | 5 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | UNKNOWN | 20785 | 50 | MG | CAPSULES | TID | |||||
| 123574553 | 12357455 | 6 | SS | THALOMID | THALIDOMIDE | 1 | Oral | U | UNKNOWN | 20785 | 50 | MG | CAPSULES | BID | |||||
| 123574553 | 12357455 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | 81 | MG | UNKNOWN | QD | |||||||
| 123574553 | 12357455 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 1 | DF | TABLETS | QD | |||||||
| 123574553 | 12357455 | 9 | C | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 0 | 20 | MG | TABLETS | Q8H | |||||||
| 123574553 | 12357455 | 10 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | 25 | MG | TABLETS | BID | |||||||
| 123574553 | 12357455 | 11 | C | TORSEMIDE. | TORSEMIDE | 1 | Oral | 0 | 50 | MG | TABLETS | QD | |||||||
| 123574553 | 12357455 | 12 | C | COUMADIN | WARFARIN SODIUM | 1 | Oral | 0 | 4 | MG | TABLETS | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123574553 | 12357455 | 1 | Arteriovenous malformation |
| 123574553 | 12357455 | 2 | Gastrointestinal haemorrhage |
| 123574553 | 12357455 | 7 | Product used for unknown indication |
| 123574553 | 12357455 | 8 | Hypertension |
| 123574553 | 12357455 | 9 | Pulmonary hypertension |
| 123574553 | 12357455 | 10 | Cardiac failure chronic |
| 123574553 | 12357455 | 11 | Cardiac failure chronic |
| 123574553 | 12357455 | 12 | Anticoagulant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123574553 | 12357455 | OT |
| 123574553 | 12357455 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123574553 | 12357455 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123574553 | 12357455 | 1 | 201212 | 0 | ||
| 123574553 | 12357455 | 2 | 20130323 | 0 | ||
| 123574553 | 12357455 | 3 | 20130802 | 0 | ||
| 123574553 | 12357455 | 4 | 201501 | 0 | ||
| 123574553 | 12357455 | 5 | 201605 | 0 | ||
| 123574553 | 12357455 | 6 | 201606 | 0 | ||
| 123574553 | 12357455 | 8 | 2011 | 0 | ||
| 123574553 | 12357455 | 9 | 2013 | 0 | ||
| 123574553 | 12357455 | 10 | 2013 | 0 | ||
| 123574553 | 12357455 | 11 | 2011 | 0 | ||
| 123574553 | 12357455 | 12 | 2011 | 0 |